We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+9.79%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.75%
AUM
$15.7B
AUM Growth
+$2.32B
(+17%)
Cap. Flow
+$1.26B
Cap. Flow
% of AUM
8.02%
Top 10 Holdings %
Top 10 Hldgs %
18.6%
Holding
1,228
New
419
Increased
306
Reduced
272
Closed
217
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$224M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$202M |
| 3 |
Vodafone
VOD
|
+$185M |
| 4 |
General Motors
GM
|
+$183M |
| 5 |
Infosys
INFY
|
+$111M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GSK
GSK
|
+$238M |
| 2 |
TSMC
TSM
|
+$157M |
| 3 |
AstraZeneca
AZN
|
+$151M |
| 4 |
Netflix
NFLX
|
+$148M |
| 5 |
Intel
INTC
|
+$99.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.99% |
| 2 | Technology | 17.62% |
| 3 | Communication Services | 12.58% |
| 4 | Consumer Staples | 9.85% |
| 5 | Financials | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Vodafone
VOD
$35.1B
| $450M | 2.86% |
12,559,498
+5,859,274
| +87% | +$185M |
|
|
2
Cisco
CSCO
$444B
| $418M | 2.66% |
17,862,531
+9,028,985
| +102% | +$224M |
|
3
Philip Morris
PM
$298B
| $363M | 2.31% |
4,189,356
-903,664
| -18% | -$79M |
|
|
4
GSK
GSK
$102B
| $280M | 1.78% |
4,470,231
-3,703,138
| -45% | -$238M |
|
5
Comcast
CMCSA
$78.3B
| $266M | 1.69% |
11,802,628
+1,585,928
| +16% | +$34.5M |
|
6
Pfizer
PFE
$143B
| $257M | 1.63% |
9,431,797
+3,160,623
| +50% | +$86M |
|
7
BP
BP
$113B
| $245M | 1.55% |
7,113,966
+2,226,153
| +46% | +$76.4M |
|
|
DTV
8
DELISTED
DIRECTV COM STK (DE)
DTV
| $219M | 1.39% |
3,669,434
-866,677
| -19% | -$53.4M |
|
|
9
Alphabet (Google) Class C
GOOG
$3.89T
| $214M | 1.36% |
9,813,566
+9,145,351
| +1,369% | +$202M |
|
10
Eli Lilly
LLY
$1.06T
| $214M | 1.36% |
4,245,810
-79,115
| -2% | -$4.14M |
|
|
11
General Motors
GM
$73B
| $203M | 1.29% |
5,639,773
+5,101,628
| +948% | +$183M |
|
|
CELG
12
DELISTED
Celgene Corp
CELG
| $174M | 1.11% |
2,258,588
+906,698
| +67% | +$63.5M |
|
13
Amgen
AMGN
$201B
| $173M | 1.1% |
1,547,012
+306,651
| +25% | +$33.3M |
|
14
American International
AIG
$41.4B
| $172M | 1.1% |
3,546,214
+474,410
| +15% | +$22.5M |
|
15
Nokia
NOK
$54.3B
| $171M | 1.09% |
26,329,673
-6,205,018
| -19% | -$29.3M |
|
16
Corning
GLW
$134B
| $168M | 1.07% |
11,488,145
-6,120,868
| -35% | -$90.6M |
|
17
Biogen
BIIB
$29.6B
| $165M | 1.05% |
684,173
+66,404
| +11% | +$14.9M |
|
18
AbbVie
ABBV
$454B
| $164M | 1.04% |
3,667,075
-1,159,690
| -24% | -$51.4M |
|
|
19
AstraZeneca
AZN
$261B
| $164M | 1.04% |
3,156,398
-3,005,328
| -49% | -$151M |
|
20
Gilead Sciences
GILD
$162B
| $162M | 1.03% |
2,580,322
+1,072,859
| +71% | +$64.1M |
|
|
CMCSK
21
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
| $146M | 0.93% |
3,364,642
-1,032,529
| -23% | -$44.8M |
|
22
Citigroup
C
$221B
| $141M | 0.9% |
2,912,257
+1,673,176
| +135% | +$84.6M |
|
|
23
Infosys
INFY
$43.2B
| $141M | 0.89% |
23,398,856
+18,711,288
| +399% | +$111M |
|
24
Costco
COST
$411B
| $141M | 0.89% |
1,220,709
+241,228
| +25% | +$27.8M |
|
25
AutoZone
AZO
$47.7B
| $127M | 0.81% |
299,936
-4,015
| -1% | -$1.72M |
|
Similar funds
VGA
Arrowstreet Capital's Q3 2013 Portfolio in Review
As of Q3 2013, Arrowstreet Capital held 1,228 positions worth $15.7B, up 17% from $13.4B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Arrowstreet Capital deployed $1.26B of net new capital in Q3 2013, opening 419 new positions and adding to 306 existing holdings. Its largest new stake was Ericsson: 5,508,729 shares worth $73.5M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 24% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was GSK, an estimated $238M trimmed.
- Arrowstreet Capital's largest Q3 2013 buy was Ericsson: 5,508,729 shares worth $73.5M.
- Arrowstreet Capital added most to Cisco in Q3 2013, an estimated $224M increase.
- Arrowstreet Capital's biggest Q3 2013 reduction was GSK, cutting an estimated $238M.
- Arrowstreet Capital fully exited TSMC in Q3 2013, selling an estimated $157M.
- Arrowstreet Capital's ten largest holdings make up 19% of its $15.7B portfolio in Q3 2013.
- Arrowstreet Capital opened 419 new positions and closed 217 in Q3 2013.
- Arrowstreet Capital's portfolio value rose 17% quarter-over-quarter to $15.7B.
Based on Arrowstreet Capital's 13F filing for Q3 2013, filed 14 Nov 2013.